Safety Blood Collection / Infusion Set (with/without needle holder), Blood Collection / Infusion Set (with/without needle holder)

K214075 · Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. · FMI · Apr 12, 2022 · General Hospital

Device Facts

Record IDK214075
Device NameSafety Blood Collection / Infusion Set (with/without needle holder), Blood Collection / Infusion Set (with/without needle holder)
ApplicantAnhui Hongyu Wuzhou Medical Manufacturer Co., Ltd.
Product CodeFMI · General Hospital
Decision DateApr 12, 2022
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 880.5570
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Safety Blood Collection / Infusion Set (with/without needle holder) is indicated for venous blood collection and/or the short-term infusion of intravenous fluids for 2 hours or less. It is to be used by appropriately trained healthcare professionals in accordance with the instructions. The safety shield is intended to aid in the protection against accidental needle stick injury. The Blood Collection / Infusion Set (with/without needle holder) is indicated for venous blood collection and/or the short-term infusion of intravenous fluids for 2 hours or less. It is to be used by appropriately trained healthcare professionals in accordance with the instructions.

Device Story

Single-use, sterile, winged needle set; includes flexible tubing, Luer connector, and optional needle holder. Safety version features integrated shield; user slides shield over needle post-venipuncture until audible click locks mechanism, preventing reuse and protecting against needlestick injury. Used by trained healthcare professionals in clinical settings for blood sampling or short-term fluid administration. Connects to standard Luer-compatible accessories (e.g., syringes, holders). Device provides physical access to venous system; safety mechanism reduces sharps exposure risk for clinicians.

Clinical Evidence

No clinical data. Substantial equivalence supported by bench testing, including biocompatibility (ISO 10993-1), sterility (ISO 11135), and mechanical performance (ISO 8536-4, ISO 9626, ISO 7864, ISO 80369-7, ISO 23908, ISO 6009).

Technological Characteristics

Materials: SUS304 needle, PVC tubing, ABS Luer adapter, HDPE/PP components, Isoprene rubber sleeve. Energy: None (manual). Connectivity: None. Sterilization: Ethylene Oxide (EO) per ISO 11135. Form factor: Winged needle with flexible tubing and Luer lock. Safety mechanism: Manual sliding shield with locking latch.

Indications for Use

Indicated for venous blood collection and/or short-term (≤2 hours) IV fluid infusion. For use by trained healthcare professionals.

Regulatory Classification

Identification

A hypodermic single lumen needle is a device intended to inject fluids into, or withdraw fluids from, parts of the body below the surface of the skin. The device consists of a metal tube that is sharpened at one end and at the other end joined to a female connector (hub) designed to mate with a male connector (nozzle) of a piston syringe or an intravascular administration set.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the logos of the Department of Health & Human Services and the Food and Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue. April 12, 2022 Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. % Charles Mack Principal Engineer IRC 2950 E Lindrick Drive Chandler, Arizona 85249 Re: K214075 Trade/Device Name: Safety Blood Collection / Infusion Set (with/without needle holder), Blood Collection / Infusion Set (with/without needle holder) Regulation Number: 21 CFR 880.5570 Regulation Name: Hypodermic Single Lumen Needle Regulatory Class: Class II Product Code: FMI, FPA Dated: March 18, 2022 Received: March 24, 2022 Dear Charles Mack: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal {1}------------------------------------------------ statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Gang Peng for Payal Patel Assistant Director DHT3C: Division of Drug Delivery and General Hospital Devices, and Human Factors OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ### Indications for Use 510(k) Number (if known) K214075 #### Device Name Safety Blood Collection / Infusion Set (with/without needle holder) Blood Collection / Infusion Set (with/without needle holder) #### Indications for Use (Describe) The Safety Blood Collection / Infusion Set (with/without needle holder) is indicated for venous blood collection and/or the short-term infusion of intravenous fluids for 2 hours or less. It is to be used by appropriately trained healtheare professionals in accordance with the instructions. The safety shield is intended to aid in the protection against accidental needle stick injury. The Blood Collection / Infusion Set (with/without needle holder) is indicated for venous blood collection and/or the shortterm infusion of intravenous fluids for 2 hours or less. It is to be used by appropriately trained healthcare professionals in accordance with the instructions. | Type of Use (Select one or both, as applicable) | | |-------------------------------------------------|--| |-------------------------------------------------|--| X Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ # K214075 510(k) SUMMARY # Submitter Information: | Preparation Date: | April 3, 2022 | |------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Manufacturer's Name and Address: | Anhui Hongyu Wuzhou Medical<br>Manufacturer Co., Ltd.<br>No. 2 Guanyin Road, Economic<br>Development Zone, Taihu, Anqing City,<br>Anhui Province, China 246400<br>Mr. Bingyi Xiang<br>General Manager<br>Tel: +86-556 5129666<br>Fax: +86-556 4249999<br>birrell@hongyu-wuzhou.com | | Submission Corresponding Official: | Charles Mack | | Telephone Number: | 931-625-4938 | | Email Address: | charliemack@irc-us.com | | Trade Name: | Safety Blood Collection / Infusion Set<br>(with/without needle holder) | | | Blood Collection / Infusion Set<br>(with/without needle holder) | | Common Name(s): | Needle, hypodermic, single lumen<br>Intravascular administration set | | Regulation Name(s): | Needle, hypodermic, single lumen<br>Intravascular administration set | | Regulation Number(s): | 21CFR 880.5570 | | Product Code: | FMI, FPA | | Device Class: | Class II | | Predicate Device: | K173757<br>VACUETTE EVOPROTECT Safety Blood<br>Collection/Infusion Set<br>Greiner Bio-One NA Inc | {4}------------------------------------------------ ## Device Description: The Blood Collection / Infusion Set (with/without needle holder) is a single-use, sterile, winged needle bonded to flexible tubing with a Luer connector. The Blood Collection / Infusion Set (with/without a needle holder) is individually wrapped and sterile with a luer port. The luer port can connect FDA cleared accessories like luer adapter, holder, etc. The Safety Blood Collection / Infusion Set (with/without needle holder) is a single-use, sterile, winged needle bonded to flexible tubing with a Luer connector and a safety mechanism. The winged needle is designed with a safety mechanism, which allows for activation, ensuring the needle is covered immediately following venipuncture to protect against accidental needlestick injury. The Safety Blood Collection / Infusion Set (with/without a needle holder) is individually wrapped and sterile with a luer port. The luer port can connect FDA cleared accessories like luer adapter, holder, etc. The safety feature is easily operated by releasing a latch mechanism whereby the user slides a winged cover over the needle removed from the patient. Once the needle is covered, the safety cover locks in place. There is no ability to clean and reuse these devices because the safety feature cannot be deactivated without bending the needle and rendering it unusable. The Blood Collection / Infusion Set (with/without needle holder) and Safety Blood Collection / Infusion Set (with/without needle holder) are used for venous blood collection and/or the short-term infusion of intravenous fluids. It can be used with an intravascular administration set or a syringe or other device to administer fluids. The product is to be used by appropriately trained healthcare professionals only in accordance with the manufacturer's instructions. {5}------------------------------------------------ | Blood Collection / Infusion Set | Individually wrapped and sterile, allowing set to be used with a luer system. | |-----------------------------------------------------|------------------------------------------------------------------------------------------------| | Blood Collection Set (without needle holder) | Individually wrapped and sterile with Luer Adapter (for use with e.g. Standard Needle holder). | | Blood Collection Set (with needle holder) | Individually wrapped and sterile, ready to be used forblood collection. | | Safety Blood Collection / Infusion Set | Individually wrapped and sterile, allowing set to be used with a luer system. | | Safety Blood Collection Set (without needle holder) | Individually wrapped and sterile with Luer Adapter (for use with e.g. Standard Needle holder). | | Safety Blood Collection Set (with needle holder) | Individually wrapped and sterile, ready to be used forblood collection. | The proposed device consists of the components defined below: - 1. needle holder - 2. rubber sleeve - 3. puncture needle - 4. needle hub (male luer lock connector) - 5. connect base (female luer lock connector) - 6. flexing tube - 7. safety shield - 8. wings - 9. patient-end tube needle - 10. needle sheath - 11. Protective cap # Indications for Use The Safety Blood Collection / Infusion Set (with/without needle holder) is indicated for venous blood collection and/or the short-term infusion of intravenous fluids for 2 hours or less. It is to be used by appropriately trained healthcare professionals in accordance with the instructions. The safety shield is intended to aid in the protection against accidental needle stick injury. The Blood Collection / Infusion Set (with/without needle holder) is indicated for venous blood collection and/or the short-term infusion of intravenous fluids for 2 hours or less. It is to be used by appropriately trained healthcare professionals in accordance with the instructions. {6}------------------------------------------------ # SE Comparison Table | Feature | Subject Device | Predicate Device | Discussion | |-----------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------| | Company | Anhui Hongyu Wuzhou<br>Medical Manufacturer Co., Ltd. | Greiner Bio-One NA Inc | - | | FDA510(K)<br>Number | K214075 | K173757 | - | | Device Name | Safety Blood Collection /<br>Infusion Set (with/without<br>needle holder);<br>Blood Collection / Infusion Set<br>(with/without needle holder) | VACUETTE<br>EVOPROTECT<br>Safety Blood<br>Collection / Infusion<br>Set | - | | Product code | FMI, FPA | FMI, FPA | - | | CFR | 880.5570 | 880.5570 | - | | Indication for<br>Use | The Safety Blood Collection /<br>Infusion Set (with/without<br>needle holder) is indicated for<br>venous blood collection and/or<br>the short-term infusion of<br>intravenous fluids for 2 hours<br>or less. It is to be used by<br>appropriately trained<br>healthcare professionals in<br>accordance with the<br>instructions. The safety shield<br>is intended to aid in the<br>protection against accidental<br>needle stick injury.<br><br>The Blood Collection / Infusion<br>Set (with/without needle<br>holder) is indicated for venous<br>blood collection and/or the<br>short-term infusion of<br>intravenous fluids for 2 hours<br>or less. It is to be used by<br>appropriately trained<br>healthcare professionals in<br>accordance with the<br>instructions. | The VACUETTE<br>EVOPROTECT<br>Safety Blood<br>Collection/Infusion<br>Set is indicated for<br>venous blood<br>collection and/or the<br>short-term infusion of<br>intravenous fluids. It<br>is to be used by<br>appropriately trained<br>healthcare<br>professionals in<br>accordance with the<br>instructions. | Note 1 | | Feature | Subject Device | Predicate Device | Discussion | | Safe Feature | For the Safety Blood Collection / Infusion Set<br>(with/without needle holder), the needle is locked in the<br>safety sheath after using the safety shield by pulling the<br>tubing backward until an audible click is heard.<br><br>There is no safety mechanism for the Blood Collection /<br>Infusion Set (with/without needle holder). | The needle is completely retracted and locked by sliding<br>the safety shield forward and pulling the tubing backward<br>until an audible click is heard. | Note 2 | | Material | | | | | Needle tube | SUS304 | SUS304 | Identical | | Flexing tube | PVC | PVC | Identical | | Luer adapter | ABS | ABS | Identical | | Needle sheath | HDPE | PP | Note 3 | | Safety shield | Polypropylene | PC | | | Rub sleeve | Gather Isoprene Rubber | Unknown | | | Lubricate | Silicone oil | Unknown | | | Adhesive | Epoxy Resin | UV cured adhesive | | | Needle Gauge | 18G, 19G, 20G, 21G, 22G,<br>23G, 24G, 25G, 26G, 27G; | 21G, 23G, 25G | Note 4 | | Needle Length | 1/2" - 1 1/8" | 3/4' | | | Flexing tubing<br>Length | 7½"; 12" | 4"; 7½"; 12" | Note 5 | | Hub/Needle<br>bond strength | Complies with ISO7864 | Complies with<br>ISO7864 | Identical | | Biocompatibility | Complies with ISO10993-1 | Complies with<br>ISO10993-1 | Identical | | Performance | Complies with<br>ISO 9626<br>ISO 7864<br>ISO 80369-7<br>ISO 80369-20<br>ISO 23908<br>ISO 6009<br>ISO 8536-4 | Complies with<br>ISO 9626<br>ISO 7864<br>ISO 80369-7<br>ISO 80369-20<br>ISO 23908<br>ISO 6009<br>ISO 8536-4 | Identical | | Sterilization | EO | Rx | Note 6 | | Sterile | Yes | Yes | Identical | | SAL | 10^-6 | 10^-6 | Identical | | Disposable | Yes | Yes | Identical | | Single Patient<br>Use | Yes | Yes | Identical | {7}------------------------------------------------ {8}------------------------------------------------ #### Note 1 The subject devices include two configurations, with the safety mechanism and without safety mechanism, but the predicate device only includes one configuration with a safety mechanism. Although the configuration is different, the indication for use is the same, and both can be used for blood collection and infusion. Therefore, the difference is not determined to affect substantially equivalence on safety and effectiveness. #### Note 2 For the Safety Blood Collection / Infusion Set (with/without needle holder), the safety mechanism is the same as predicate device: There is no safety mechanism for the Blood Collection / Infusion Set (with/without needle holder). Whether there is a safety mechanism will not affect the indication for the use of the devices; both can be used for blood collection and infusion. Therefore, the difference is not determined to affect substantially equivalence on safety and effectiveness. ### Note 3 Although the material of these components of subject devices are different from predicate devices (or some unknown for predicate device), they conform to the same ISO10993-1 biocompatibility standards; Therefore, the difference does not raise new questions on the safety and effectiveness of the proposed method device. #### Note 4 The subject devices' needle gauge and needle length are available in more sizes than the predicate device, but they conform to the same applicable performance standards as the predicate device; Therefore, the difference does not raise new questions on the safety and effectiveness of the proposed method device. ## Note 5 The subject device has two sizes, same as the predicate device, but the predicate device has an additional one size: They conform to the same applicable performance standards. Therefore, this difference is not considered to affect safety and effectiveness substantially. #### Note 6 The sterilization method is different; The subject device's sterilization is validated per ISO11135 and achieves the same SAL of 10° as the predicate device. The difference will not affect the Substantial Equivalence (SE) between the proposed and predicate device {9}------------------------------------------------ # Performance Testing Performance testing was provided in support of the substantial equivalence determination and to validate and verify that the Safety Blood Collection / Infusion Set (with/without needle holder) and Blood Collection/Infusion set (with/without needle holder) met all requirements of related international standards, including biocompatibility, sterility, and product specifications. These tests demonstrate compliance with the requirements of the consensus standards noted below. ## Non-clinical Testing ## Performance Testing - ISO 8536-4-2019 Infusion equipment for medical use —Part 4: Infusion sets for single-use, gravity feed - ISO 9626 Second edition 2016-08-01 Stainless steel needle tubing for the manufacture of medical devices - Requirements and test methods - -ISO 7864 Fourth edition 2016-08-01 Sterile hypodermic needles for single use -Requirements and test methods - ISO 80369-7 First edition 2016-10-15 Small-bore connectors for liquids and gases in healthcare applications - Part 7: Connectors for intravascular or hypodermic applications - ISO 80369-20 First edition 2015-05-15, small-bore connectors for liquids and gases in healthcare applications part 20: common test methods. (General I (QS/RM)) - ISO 23908 First edition 2011-06-11 Sharps injury protection Requirements and test methods - Sharps protection features for single-use hypodermic needles, introducers for catheters and needles used for blood sampling - ISO 6009 Fourth edition 2016-08-01 Hypodermic needles for single use Colour coding for identification - ISO 2859-1 Second edition 1999-11-15 Sampling procedures for inspection by attributes - Part 1: Sampling schemes indexed by acceptance quality limit (AQL) for lot-by-lot inspection [Including: Technical Corrigendum 1 (2001), Amendment 1 (2011)] - USP 788 Particulate Matter in Injections - - Flowrate and Priming volume of tubing l {10}------------------------------------------------ ### Biocompatibility The new device complies with the biocompatibility requirement defined in ISO10993-1. Patient contact classification: externally communicating devices, contact circulating blood for limited contact (<24 h) duration. The verification test shows that the new devices comply with the biocompatibility requirement defined in ISO10993-1, the same as the predicate device. - In Vitro Cytotoxicity (ISO10993-5: 2009) - - Skin Sensitization (ISO10993-10: 2010) - - -Intracutaneous Reactivity Test (ISO10993-10: 2010) - Acute Systemic toxicity (ISO10993-11:2006) - - Coagulation (ISO10993-4:2017) - - Complement Activity Test (ISO10993-4: 2017) - - Hemolytic Properties Test (ISO10993-4: 2017, ASTM F756-17) - - -Ames Test (ISO10993-3:2014) - Mammalian Chromosome Aberration Test (ISO10993-3:2014) - - -Mammalian Erythrocyte Micronucleus Test (ISO10993-3:2014) All of the pre-determined acceptance criteria were met. #### Sterility Information The devices are EO sterilized. The sterilization was conducted according to the following standards: - ISO11135-1 Sterilization of health care products ethylene oxide part 1: requirements for the development, validation, and routine control of a sterilization process for medical devices. - ISO11737-1 Sterilization of medical devices-Microbiological Methods-Part 1: -Determination of the population of microorganisms on the product. - -ISO11737-2 Sterilization of medical devices -- Microbiological methods -- Part 2: Tests of sterility performed in the validation of a sterilization process. - -ISO10993-7 Biological evaluation of medical devices - Part 7: Test of Ethylene Oxide Residuals. - ANSI/AAMI ST72 Bacterial endotoxins Test methods, routine monitoring, and alternatives to batch testing. All of the pre-determined acceptance criteria were met. {11}------------------------------------------------ #### Package and Shelf Life: We conducted the below package and shelf life verification test to support the shelf life claim according to the standards noted below: - AAMI/ANSI/ISO 11137-1:2006/(R) 2010 Sterilization of health care products - - Radiation - Part 1: Requirements for development, validation, and routine control of a sterilization process for medical devices - AAMI/ANSI/ISO11737-2:2009 Sterilization of of medical devices Microbiological methods - Part 2: Tests of sterility performed in the definition, validation, and maintenance of a sterilization process - AAMI/ANSI/ISO 11607-1:2006/(R) 2010 Packaging for terminally sterilized medical devices - Part 1: Requirements for materials, sterile barrier systems, and packaging systems, 3ed. - ASTM F1929-98 (2004) Standard Test Method for Detecting Seal Leaks in -Porous Medical Packaging by Dye Penetration - ASTM F1980-07 Standard Guide for Accelerated Aging of Sterile Barrier -Systems for Medical Devices - ASTM D3078-02 (2008), Standard Test Method for Determination of Leaks in Flexible Packaging by Bubble Emission. (Sterility) - -ASTM F88/F88M-09 Standard Test Method for Seal Strength of Flexible Barrier Materials The tests were conducted as noted below: - Accelerated Aging Test - Simulated shipping distribution testing - Visual inspection - Performance Inspection - Sterile Test - Vacuum Leak Test - Dye penetration test - Agar Contact-Attack Test - Tensile Seal Strength Test {12}------------------------------------------------ The test result supports the shelf life claim for the subject device from the sterilization date. All of the pre-determined acceptance criteria were met. ## Clinical Test: No clinical study is included in this submission. ## Conclusions: The differences between the predicate and the subject device do not raise any new or different questions of safety or effectiveness. The Safety Blood Collection / Infusion Set (with/without needle holder) and Blood Collection/Infusion set (with/without needle holder) are substantially equivalent to the Greiner Bio-One NA Inc VACUETTE EVOPROTECT Safety Blood Collection / Infusion Set cleared under K173757 with respect to the indications for use, target populations, treatment method, and technological characteristics. END
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...